TABLE 7.
Route of Administration | Intravenous | Oral | Mdr1a/b−/− Bcrp1−/− | |||
---|---|---|---|---|---|---|
Wild Type | Mdr1a/b−/− Bcrp1−/− | Wild Type | Bcrp1−/− | Mdr1a/b−/− | ||
AUC0→∞, plasma | 15,915 | 15,915 | 63,748 | 63,955 | 63,503 | 64,165 |
AUC0→∞, brain | 404 | 11,462 | 1243 | 1859 | 71,308 | 68,317 |
Kppreda | 0.025 | 0.72 | 0.019 | 0.029 | 1.12 | 1.06 |
DApredb | — | 28 | — | 1.5 | 58 | 55 |
Clin | 0.131 | 0.131 | 0.138 | 0.138 | 0.138 | 0.138 |
Clout | 5.1 | 0.181 | 7.1 | 4.7 | 0.118 | 0.126 |
CLin/CLoutc | 0.026 | 0.72 | 0.019 | 0.029 | 1.17 | 1.10 |
DApredd | — | 28 | — | 1.5 | 60 | 56 |
Kppred, the ratio of model predicted AUC0→∞, brain to model predicted AUC0→∞, plasma.
DApred (distribution advantage), the ratio of Kpknockout to Kpwild-type.
The ratio of model predicted clearance into the brain to model predicted clearance out of the brain compartment.
DApred (distribution advantage), the ratio of brain clearance ratio in wild-type to brain clearance ratio in transgenic mice.